Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
40.51
+0.54 (1.35%)
At close: Jul 9, 2026, 4:00 PM EDT
40.94
+0.43 (1.06%)
Pre-market: Jul 10, 2026, 4:40 AM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $6.92 billion as of July 10, 2026. Its market cap has increased by 739.37% in one year.
Market Cap
6.92B
Enterprise Value
6.30B
1-Year Change
739.37%
Ranking
Category
Stock Price
$40.51
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $6.92B, an increase of 5,471.41%. That is a compound annual growth rate of 95.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 6.92B | 28.13% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TG Therapeutics | 8.11B |
| Rhythm Pharmaceuticals | 7.84B |
| Mirum Pharmaceuticals | 7.84B |
| PTC Therapeutics | 7.35B |
| Xenon Pharmaceuticals | 6.76B |
| Scholar Rock Holding | 6.71B |
| Ligand Pharmaceuticals | 6.24B |
| CG Oncology | 6.16B |